Table 3.

Immune/inflammatory genes upregulated after ischemia (30 min) and 2d reperfusion compared with 2d sham-operated animals

Probe IDDescriptionSymbolMeanSD
1387316_atchemokine (C-X-C motif) ligand 1; groGro17.93.7
1369191_atinterleukin 6Il67.73.0
1367850_atFc receptor, IgG, low affinity IIIFcgr34.21.7
1398246_s_atFc receptor, IgG, low affinity IIIFcgr33.91.7
1367973_atchemokine (C-C motif) ligand 2Ccl23.61.0
1367581_a_atsecreted phosphoprotein 1Spp13.51.4
1368683_atoxidised low density lipoprotein (lectin-like) receptor 1Olr13.40.8
1368490_atCD14 antigenCd142.81.0
1390798_atprotein tyrosine phosphatase, receptor type, CPtprc2.30.5
1369665_a_atinterleukin 18Il182.00.2
1387742_atchemokine receptor CCR2 geneCcr21.80.0
  • Data presented indicate fold change (mean ± SD) in expression of ischemia (30 min) and reperfusion (2d) compared with corresponding sham-operated control sample. Data correspond to Fig. 4, cluster D.